Atmo Biosciences

What does success look like to you?

Commercialising a medical device that improves quality of life for the millions of sufferers of common GI conditions, and demystifying microbiome function by opening up a window and shining a light on what is the black box of gut physiology.

Malcolm Hebblewhite

Co-founder and CEO, Atmo Biosciences

Malcolm Hebblewhite is an executive and entrepreneur with more than 25 years of technical, commercial and international business experience in medical device and technology-based product development. Mal was a pre-IPO employee of ResMed (NYSE:RMD;ASX:RMD), and held executive roles of increasing responsibility for the company in business development, marketing and M&A in Australia, the USA, and Europe. More recently, Mal worked in commercial and business development roles at leading healthtech innovation company Planet Innovation, before founding Atmo Biosciences in 2018. He holds a B.E.(Hons)(Aerospace) from UNSW, an MBA from the Kellogg Graduate School of Business at Northwestern University.

Would you like to call out a mentor who has helped your company? Tell us a little about them.

Professor Peter Gibson, chief clinical advisor, who has provided dedicated and valuable leadership throughout the life of the company. Professor Kourosh Kalantar-zadeh, leader of the group at RMIT that invented the technology, for his vision and creativity.